This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Market Hustle: Futures Rise Despite More China Weakness

NEW YORK (TheStreet) -- U.S. stock futures were pointing higher Monday as investors looked for further signs of U.S. economic improvement while digesting mixed growth signals from overseas.

  • S&P 500 futures were up 3.25 points, or 3.68 points above fair value, to 1,828.75, futures for the Dow Jones Industrial Average were rising 31 points, or 41.01 points above fair value, to 16,438, and Nasdaq futures were up 1.8 points, or 0.67 points above fair value, to 3,533.3.

  • The Institute for Supply Management's December services sector report is expected at 10 a.m. EST while the November factory orders report is scheduled for 10 a.m. The services sector release will include the non-manufacturing employment index, a precursor to Friday's December government jobs report.

  • Major U.S. markets closed mixed on Friday as Federal Reserve Chairman Ben Bernanke gave his final prepared speech emphasizing that the U.S. economy has made considerable progress since the recovery began.

  • Minutes of the December Fed meeting will be released on Wednesday. November international trade numbers will be released on Tuesday.

  • The Senate is expected to confirm Janet Yellen's appointment as Federal Reserve chair at around 5:30 p.m. on Monday.

  • HSBC/ Markit Economics' purchasing managers' index for services industries in China showed a drop to 50.9 in December, its lowest level since August 2011. Slowing manufacturing activity in China were indicated in reports last week.

  • The upturn in the eurozone private sector economy gained momentum in December, according to Markit.

  • Idenix Pharmaceuticals (IDIX) was popping 6.54% to $6.68 and Gilead Sciences (GILD - Get Report) was rising 0.35% to $74.58. They're among a number of biotech stocks in focus as UBS and JPMorgan publishes their bullish 2014 biotech sector outlooks.

-- Written by Andrea Tse in New York.

Follow @atwtse

>Contact by Email.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG
GILD $102.27 -0.70%
IDIX $24.50 0.20%
AAPL $125.01 -0.63%
FB $78.10 0.70%
GOOG $524.22 -1.24%

Markets

DOW 17,841.98 -86.22 -0.48%
S&P 500 2,080.15 -9.31 -0.45%
NASDAQ 4,919.6440 -19.6830 -0.40%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs